comparemela.com

Latest Breaking News On - Formulation technology - Page 2 : comparemela.com

ADAMA Launches New Cereal Fungicide Forapro For Supercharged Disease Control And Higher Yields

ADAMA Launches New Cereal Fungicide Forapro For Supercharged Disease Control And Higher Yields
foodonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foodonline.com Daily Mail and Mail on Sunday newspapers.

Beijing
China
Aviv-prnewswire
Formulation-technology
Tel-aviv
Active-ingredients
Powdery-mildew
Alex-mills
Global-head
Yellow-rust

ADAMA Launches New Cereal Fungicide Forapro® for Supercharged Disease Control and Higher Yields

ADAMA Launches New Cereal Fungicide Forapro® for Supercharged Disease Control and Higher Yields
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Beijing
China
Formulation-technology
Twitter
Active-ingredients
Powdery-mildew
Global-head

ADAMA Ltd.: ADAMA Reports Fourth Quarter and Full Year 2023 Results

ADAMA Ltd.: ADAMA Reports Fourth Quarter and Full Year 2023 Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Huaian
Fujian
China
New-zealand
Argentina
India
Sweden
Ireland
Poland
Mexico
South-korea
Paraguay

ADAMA Reports Fourth Quarter and Full Year 2023 Results

Management focus led to a significant improvement in cash flow despite challenging market conditions negatively impacting sales and profit Fourth Quarter 2023.

Poland
Sweden
Ireland
Paraguay
South-korea
Shenzhen
Guangdong
China
Mexico
India
Red-sea
Djibouti-general

Modified Release Neurology Therapeutics Report 2024 - Neurology Therapeutics Advance with Modified R

DUBLIN (BUSINESS WIRE) The "Modified Release Neurology Therapeutics" report has been added to ResearchAndMarkets.com's offering.Large pharmaceutical and biotechnology companies are increasingly pursuing in-licensing to offset lower than expected drug development productivity and surging research costs. Data mining.

Polyactive-octoplus
Xbrane-bipharma
Depofoam-pacira
Q-sphera-midatech-pharma
Recipharm-avadel
Fluidcrystal-camarus
Synbiosys-innocore
Transcon-ascendis
Ascendis-pharma
Laura-wood
Eli-lilly
Formulplex-supercritical-solutions

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.